Advisor Group Holdings, Inc. Werewolf Therapeutics, Inc. Transaction History
Advisor Group Holdings, Inc.
- $42.1 Billion
- Q1 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 9,625 shares of HOWL stock, worth $11,838. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,625Holding current value
$11,838% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HOWL
# of Institutions
71Shares Held
27.3MCall Options Held
300Put Options Held
13.6K-
Ra Capital Management, L.P. Boston, MA6.14MShares$7.56 Million0.12% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.31MShares$5.3 Million6.02% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.51MShares$3.08 Million0.19% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.41MShares$2.96 Million0.43% of portfolio
-
Bank Of America Corp Charlotte, NC2.1MShares$2.59 Million0.0% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $36.3M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...